Acquisition

Release date: 8th November 2005 Embargoed until: 07:00 CLS HOLDINGS PLC ('CLS') ANNOUNCES ITS FIRST ACQUISITION OF OFFICES IN HAMBURG, GERMANY The Board of CLS is delighted to announce its intention to add Germany to its core property investment regions, which currently consist of UK, Sweden and France. In line with this strategy to build a portfolio in Germany, the Company is pleased to report the acquisition of a building in West Hamburg at a price of €3.6 million (£2.45 million) inclusive of all costs. The property, known as Frohbösestrasse 12, was constructed in April 2005 and comprises 1,993 sq m (21,453 sq ft) of offices together with 19 car parking spaces. It has the benefit of a new lease with Scope International Life Science Hamburg AG, a pharmaceutical research company, for a term of 15 years without a break at an annual rent of €248,835 (£169,630). The rent will be adjusted by reference to the German retail price index. The return on equity on the completed loan facility of €2.68 million (£1.82 million) is 22.8%, whilst the cash return on equity is 14.4%. This acquisition represents CLS' first investment in the German market for many years (having owned a property in Düsseldorf for many years). CLS intends to make further selective acquisitions in Germany, where the Company has identified an opportunity to benefit from the attractive yields and high returns on equity on a geared basis. Executive Chairman, Sten Mortstedt, commented: 'I am particularly excited by the opportunities that Germany presents as an additional core region in our portfolio. This first venture into Hamburg provides an excellent example of the quality of returns that we stand to gain from this market.' -ends- For further information, please contact: Sten Mortstedt, Executive Chairman Tom Thomson, Chief Executive & Vice Chairman Dan Bäverstam, Chief Financial Officer Steven Board, Chief Operating Officer CLS Holdings plc www.clsholdings.com Tel. +44 (0)20 7582 7766 Adam Reynolds/Ben Simons Hansard Communications Tel. 44 (0)20 7245 1100

Companies

CLS Holdings (CLI)
UK 100

Latest directors dealings